Karin Przyklenk

Prof. Karin Przyklenk

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2019 in Experimental Physiology
Verified
Journal Article
Closed access
PDF file
JSJustin D. Sprick
Justin D. Sprick
RMRobert T. Mallet
Robert T. Mallet
Karin PrzyklenkKarin Przyklenk
Karin Przyklenk
CRCaroline A. Rickards
Caroline A. Rickards

15 January 2020 in Cells
Verified
Journal Article
Open access
PDF file
AKAndrew Kulek
Andrew Kulek
AAAnthony Anzell
Anthony Anzell
JWJoseph Wider
Joseph Wider
TSThomas Sanderson
Thomas Sanderson
Karin PrzyklenkKarin Przyklenk
Karin Przyklenk
The current standard of care for acute myocardial infarction or ‘heart attack’ is timely restoration of blood flow to the ischemic region of the heart. While reperfusion is essential for the salvage of ischemic myocardium, re-introduction of blood flow paradoxically kills (rather than rescues) a population of previously ischemic cardiomyocytes—a phenomenon referred to as ‘lethal myocardial ischemia-reperfusion (IR) injury’. There is long-standing and exhaustive evidence that mitochondria are at the nexus of lethal IR injury. However, during the past decade, the paradigm of mitochondria as mediators of IR-induced cardiomyocyte death has been expanded to include the highly orchestrated process of mitochondrial quality control. Our aims in this review are to: (1) briefly summarize the current understanding of the pathogenesis of IR injury, and (2) incorporating landmark data from a broad spectrum of models (including immortalized cells, primary cardiomyocytes and intact hearts), provide a critical discussion of the emerging concept that mitochondrial dynamics and mitophagy (the components of mitochondrial quality control) may contribute to the pathogenesis of cardiomyocyte death in the setting of ischemia-reperfusion.

29 August 2016 in Basic Research in Cardiology
Verified
Journal Article
Closed access
PDF file
YDYi Dong
Yi Dong
VUVishnu V. R. Undyala
Vishnu V. R. Undyala
Karin PrzyklenkKarin Przyklenk
Karin Przyklenk

9 March 2018 in Basic Research in Cardiology
Verified
Journal Article
Closed access
PDF file
JWJoseph Wider
Joseph Wider
VUVishnu V. R. Undyala
Vishnu V. R. Undyala
PWPeter Whittaker
Peter Whittaker
JWJames Woods
James Woods
XCXuequn Chen
Xuequn Chen
Karin PrzyklenkKarin Przyklenk
Karin Przyklenk

21 May 2019 in Journal of Cerebral Blood Flow & Metabolism
Verified
Journal Article
Open access
PDF file
CSChristos D Strubakos
Christos D Strubakos
MMMichelle Malik
Michelle Malik
JWJoseph M Wider
Joseph M Wider
ILIcksoo Lee
Icksoo Lee
CRChristian A Reynolds
Christian A Reynolds
TSThomas Sanderson
Thomas Sanderson
Ischemic stroke is a debilitating disease that causes significant brain injury. While restoration of blood flow is critical to salvage the ischemic brain, reperfusion can exacerbate damage by inducing generation of reactive oxygen species (ROS). Recent studies by our group found that non-invasive mitochondrial modulation with near-infrared (NIR) light limits ROS generation following global brain ischemia. NIR interacts with cytochrome c oxidase (COX) to transiently reduce COX activity, attenuate mitochondrial membrane potential hyperpolarization, and thus reduce ROS production. We evaluated a specific combination of COX-inhibitory NIR (750 nm and 950 nm) in a rat stroke model with longitudinal analysis of brain injury using magnetic resonance imaging. Treatment with NIR for 2 h resulted in a 21% reduction in brain injury at 24 h of reperfusion measured by diffusion-weighted imaging (DWI) and a 25% reduction in infarct volume measured by T2-weighted imaging (T2WI) at 7 and 14 days of reperfusion, respectively. Additionally, extended treatment reduced brain injury in the acute phase of brain injury, and 7 and 14 days of reperfusion, demonstrating a >50% reduction in infarction. Our data suggest that mitochondrial modulation with NIR attenuates ischemia–reperfusion injury and evokes a sustained reduction in infarct volume following ischemic stroke.

9 August 2017 in Journal of Cardiovascular Pharmacology and Therapeutics
Verified
Journal Article
Closed access
Karin PrzyklenkKarin Przyklenk
Karin Przyklenk
PWPeter Whittaker
Peter Whittaker
Data obtained in both preclinical models and humans have revealed that the favorable cardiac consequences of ischemic conditioning extend beyond a direct effect on the cardiomyocyte. In the current review, we summarize our as-yet limited understanding of the complex relationships between ischemic conditioning, platelet activation–aggregation, and cardioprotection.